Request Deal Involvement

Carlyle Group and SK Capital Partners completed the acquisition of bluebird bio for $96m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Leerink Partners

financial advisors

Leerink Partners

Latham & Watkins

legal advisors

Latham & Watkins

Bourne Partners

financial advisors

Bourne Partners

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Orrick Herrington & Sutcliffe

legal advisors

Orrick Herrington & Sutcliffe

or

Principals

BLUEBIRD BIO

target

BLUEBIRD BIO

THE CARLYLE GROUP

bidder

THE CARLYLE GROUP

SK CAPITAL PARTNERS

bidder

SK CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite